KIA
TMO icon

Kraematon Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Kraematon Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45
Closed -$24.8K – 232
2022
Q4 		$24.8K Buy
+45
New +$23.8K 0.03% 156

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Kraematon Investment Advisors's TMO Position: Q1 2023 in Review

Kraematon Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 45 shares — an estimated $24.8K sold.

Kraematon Investment Advisors first reported a position in TMO in Q4 2022 and held it in 1 quarter. The position peaked at $24.8K in Q4 2022. 2,385 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Kraematon Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Kraematon Investment Advisors sold 45 Thermo Fisher Scientific shares in Q1 2023, an estimated $24.8K.
  • Kraematon Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 1 quarter.
  • Kraematon Investment Advisors's Thermo Fisher Scientific position peaked at $24.8K in Q4 2022.
  • 2,385 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Kraematon Investment Advisors's 13F filing for Q1 2023, filed 13 Apr 2023.